Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Socioeconomic Status Bears Little Impact on Survival Rates

June 10th 2011

Primary cancers of the lung, esophagus, and pancreas-all of which have a poor prognosis-account for >35% of all cancer deaths in the United States annually

Chemoradiotherapy Before Surgery May Prolong Survival in Locally Advanced Lung Cancer

June 9th 2011

Patients with node-negative, locally advanced lung tumors who undergo induction chemoradiotherapy appear to survive significantly longer than patients who undergo surgical resection without induction chemoradiotherapy

Pemetrexed Maintenance Improves Progression-Free Survival in Patients With NSCLC

June 6th 2011

Continuation maintenance with pemetrexed (Alimta) improves progression-free survival in patients with advanced nonsquamous non–small cell lung cancer

Dr. Kris on the Use of Genetic Testing in Lung Cancer

June 6th 2011

Dr. Kris From Memorial Sloan-Kettering Cancer Center on the Use of Genetic Testing in Lung Cancer

Genetic Testing Delivers Personalized Lung Cancer Therapy

June 5th 2011

Taking a page from breast cancer treatment, clinicians managing lung cancer patients can now detect mutations that drive the development of lung cancer

Fish Oil Helps Chemotherapy Patients Maintain Weight and Muscle Mass

May 25th 2011

A Canadian study has found that a daily fish oil supplement can thwart chemotherapy-induced muscle and weight loss in lung cancer patients

NCCN's 16th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care

May 24th 2011

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

FDA Grants Priority Review to Pfizer's Crizotinib

May 19th 2011

Crizotinib was accepted for filing by the FDA and granted Priority Review status

ASTRO Issues Guidelines for Palliative Lung Cancer Care

May 13th 2011

ASTRO has for the first time issued its own extensive guidelines for the use of palliative thoracic radiotherapy in patients with metastatic lung cancer

ASCO Backs EGFR Testing for Lung Cancer Patients

April 15th 2011

The chorus of support is growing among oncology experts for routine genetic testing of tumors from patients with advanced non-small cell lung cancer

Lung Cancer Stigma, Smoking Status, Depression and Quality of Life

April 15th 2011

Negative attitudes toward smokers extend to patients with lung cancer, regardless of whether or not they have ever actually smoked

Targeted Therapy on the Horizon for Squamous Cell Lung Cancer?

April 10th 2011

The march toward personalized cancer care may have taken a step forward with the discovery of a potential biomarker

New Blood Test Detects Lung Cancer in Nonsmokers

April 6th 2011

Lung cancer in nonsmokers may soon have an adjunctive blood test for revealing common biomarkers

Fewer Women Dying of Lung Cancer

April 1st 2011

For the first time in at least 3 decades, the rate of women dying from lung cancer in the United States is declining

Dr. Kris on the EML4-ALK Translocation in Lung Cancer

March 25th 2011

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York on the EML4-ALK Translocation

Mentholated Cigarettes No More Harmful Than Regular Cigarettes

March 24th 2011

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop lung cancer

Dr. Kris on the Crizotinib Clinical Trials

March 23rd 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center on the Crizotinib Clinical Trials

Dr. Kris on Caring for Elderly Lung Cancer Patients

March 22nd 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering on Caring for Elderly Lung Cancer Patients

Dr. Kris Discusses EGFR Mutation Testing

March 21st 2011

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses EGFR Mutation Testing

A Leap in Lung Cancer Care: Early-Screening Success Prompts Push for Change

March 16th 2011

The National Lung Screening Trial (NLST), a randomized, national trial involving 53,000 current and former heavy smokers, compared the effects of 2 screening procedures for lung cancer

NEXT PAGE
PREVIOUS PAGE
x